Ameritas Investment Partners’s Amneal Pharmaceuticals AMRX Stock Holding History

Ameritas Investment Partners’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$268K	Buy	15,501 +2,929	+23%	+$40.1K	0.01%	1220
2026 Q1	$156K	Hold	12,572	–	–	﹤0.01%	1415
2025 Q4	$158K	Hold	12,572	–	–	﹤0.01%	1398
2025 Q3	$126K	Sell	12,572 -3,018	-19%	-$27.1K	﹤0.01%	1541
2025 Q2	$126K	Hold	15,590	–	–	﹤0.01%	1592
2025 Q1	$131K	Hold	15,590	–	–	﹤0.01%	1528
2024 Q4	$123K	Hold	15,590	–	–	﹤0.01%	1635
2024 Q3	$130K	Hold	15,590	–	–	﹤0.01%	1624
2024 Q2	$99K	Buy	15,590 +3,568	+30%	+$22.7K	﹤0.01%	1731
2024 Q1	$72.9K	Hold	12,022	–	–	﹤0.01%	1922
2023 Q4	$73K	Hold	12,022	–	–	﹤0.01%	1934
2023 Q3	$50.7K	Buy	12,022 +3,485	+41%	+$13K	﹤0.01%	2100
2023 Q2	$26.5K	Hold	8,537	–	–	﹤0.01%	2412
2023 Q1	$11.9K	Hold	8,537	–	–	﹤0.01%	2671
2022 Q4	$18.2K	Hold	8,537	–	–	﹤0.01%	2604
2022 Q3	$17K	Hold	8,537	–	–	﹤0.01%	2585
2022 Q2	$27K	Hold	8,537	–	–	﹤0.01%	2376
2022 Q1	$36K	Hold	8,537	–	–	﹤0.01%	2245
2021 Q4	$41K	Hold	8,537	–	–	﹤0.01%	2248
2021 Q3	$46K	Hold	8,537	–	–	﹤0.01%	2204
2021 Q2	$44K	Hold	8,537	–	–	﹤0.01%	2264
2021 Q1	$57K	Hold	8,537	–	–	﹤0.01%	1998
2020 Q4	$39K	Sell	8,537 -1,625	-16%	-$7.2K	﹤0.01%	2121
2020 Q3	$39K	Hold	10,162	–	–	﹤0.01%	1987
2020 Q2	$48K	Hold	10,162	–	–	﹤0.01%	1849
2020 Q1	$35K	Hold	10,162	–	–	﹤0.01%	1854
2019 Q4	$49K	Buy	10,162 +2,838	+39%	+$9.87K	﹤0.01%	1932
2019 Q3	$21K	Hold	7,324	–	–	﹤0.01%	2356
2019 Q2	$53K	Hold	7,324	–	–	﹤0.01%	1873
2019 Q1	$104K	Hold	7,324	–	–	﹤0.01%	1448
2018 Q4	$99K	Hold	7,324	–	–	0.01%	1385
2018 Q3	$163K	Hold	7,324	–	–	0.01%	1226
2018 Q2	$120K	Buy	+7,324	New	+$129K	0.01%	1411

Other funds holding AMRX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Ameritas Investment Partners's AMRX Position: Q2 2026 in Review

Ameritas Investment Partners increased its Amneal Pharmaceuticals (AMRX) stake by 23% in Q2 2026, buying an estimated $40.1K and bringing the position to 15,501 shares worth $268K. The position accounts for 0.01% of the portfolio, ranked #1220.

Ameritas Investment Partners first reported a position in AMRX in Q2 2018 and has held it in 33 quarters since. 311 funds tracked by Wall St. Rank hold AMRX as of Q2 2026.

Ameritas Investment Partners held 15,501 shares of Amneal Pharmaceuticals worth $268K as of Q2 2026.
Ameritas Investment Partners bought 2,929 Amneal Pharmaceuticals shares in Q2 2026, an estimated $40.1K.
Amneal Pharmaceuticals made up 0.01% of Ameritas Investment Partners's portfolio in Q2 2026, its #1220 holding.
Ameritas Investment Partners first reported a position in Amneal Pharmaceuticals in Q2 2018 and has held it in 33 quarters since.
311 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2026.

Based on Ameritas Investment Partners's 13F filing for Q2 2026, filed 13 Aug 2026.